%0 Journal Article
%T 肝血管瘤介入治疗的应用进展<br>Application Progress of Interventional Therapy for Hepatic Hemangioma
%A 赖博
%A 陈宝祥
%A 李艳红
%A 吴延明
%J Advances in Clinical Medicine
%P 4440-4444
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/ACM.2024.142616
%X 肝血管瘤(Hepatic hemangiomas, HHs)是成人肝脏最常见的良性肿瘤之一，包括海绵状血管瘤、上皮样血管内皮瘤以及血管肉瘤，其中以海绵状血管瘤最常见，多为良性肿瘤且无症状，一般不需要治疗。但也有特殊情况需要治疗干预，目前手术是主要的治疗方式。尽管微创技术的发展和普及取得了重大进展，但介入治疗因其创伤小、恢复快以及预后好等优点，仍是肝血管瘤不可或缺的治疗手段。本综述旨在讨论肝血管瘤的病理性质、血供类型、治疗指征，以及介入治疗的现状和进展。<br />
Hepatic hemangiomas (HHs) is one of the most common tumors in adult liver, including cavernous hemangiomas, epithelioid hemangioendotheliomas and angiosarcomas. Cavernous hemangioma is the most common, mostly benign and asymptomatic, and generally does not need treatment. How-ever, there are also special circumstances that require treatment and intervention, and surgery is the main treatment at present. Although great progress has been made in the development and popularization of minimally invasive technology, interventional therapy is still an indispensable treatment for hepatic hemangioma because of its advantages such as less trauma, rapid recovery and good prognosis. The purpose of this review is to discuss the pathological nature, blood supply type, treatment indication, current situation and progress of interventional therapy of hepatic he-mangioma.
%K 肝血管瘤，介入治疗，病理性质<br>Hepatic Hemangioma
%K Interventional Treatment
%K Pathological Properties
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=81851